The value of Ki-67 reflects only the degree of proliferative activity of the tumor cells and is not related to the clinical stage of the tumor.
Ki-67 is a nuclear protein encoded by the MKi-67 gene, also known as MKi-67. In patients undergoing surgical resection or puncture biopsy, the value of Ki-67 will be found in the pathology report, which suggests the active proliferation of cancer cells.
Generally speaking, the larger the Ki-67 value is, the more active the proliferation of cancer cells is, and the more adverse effects it has on the body. Generally, the size of the value can be used to adjust the treatment plan.
Tumor staging is a comprehensive assessment made by evaluating the size of the tumor, the status of regional lymph nodes and the presence of distant metastases, which has nothing to do with the value of Ki-67.